Andreas Kovar

Phase I Study of the Humanized Antiepidermal Growth Factor Receptor Monoclonal Antibody EMD72000 in Patients With Advanced Solid Tumors That Express the Epidermal Growth Factor Receptor

U. Vanhoefer, Mitra Tewes, Federico Rojo et al. · Journal of Clinical Oncology · 2003 · 259 citations

Medicine, Oncology, Pharmacology +15

A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer

Jan M. Langrehr, Helmut Oettle, Jochen Raedle et al. · BMC Cancer · 2006 · 122 citations · Full text

Medicine, Oncology, Pharmacology +14

Safety of Hydroxocobalamin in Healthy Volunteers in a Randomized, Placebo-Controlled Study

Wolfgang Uhl, Arno Nolting, Georg Golor et al. · Clinical Toxicology · 2006 · 112 citations

Pharmacy, Pharmacology, Pharmacotherapy +12

Population Pharmacokinetics of Cetuximab in Patients With Squamous Cell Carcinoma of the Head and Neck

Nathanae L. Dirks, Arno Nolting, Andreas Kovar et al. · The Journal of Clinical Pharmacology · 2008 · 82 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Pharmacokinetic profile of cetuximab (Erbitux™) alone and in combination with irinotecan in patients with advanced EGFR-positive adenocarcinoma

Catherine Delbaldo, Jean‐Yves Pierga, Véronique Dièras et al. · European Journal of Cancer · 2005 · 80 citations

Medicine, Oncology, Pharmacokinetics +14